PO68 TRIPLE NEGATIVE BREAST CANCER – NEOADJUVANT CHEMOTHERAPY RESPONSE EVALUATION WITH TAXANE/ANTHRACYCLINE PROTOCOL – SINGLE CENTRE 5 YEARS EXPERIENCE. (November 2015)